잠시만 기다려 주세요. 로딩중입니다.

Optimal Time Interval for Surgery After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: Analysis of Health Insurance Review and Assessment Service Data

Annals of Coloproctology 2018년 34권 5호 p.241 ~ 247
김민중, 조진숙, 김은미, Ko Woo-Ah, 오재환,
소속 상세정보
김민중 ( Kim Min-Jung ) - National Cancer Center Research Institute and Hospital Center for Colorectal Cancer
조진숙 ( Cho Jin-Suk ) - Health Insurance Review and Assessment Service
김은미 ( Kim Eun-Mi ) - Health Insurance Review and Assessment Service
 ( Ko Woo-Ah ) - Health Insurance Review and Assessment Service
오재환 ( Oh Jae-Hwan ) - National Cancer Center Research Institute and Hospital Center for Colorectal Cancer

Abstract


Purpose: Pathologic downstaging of rectal cancer has been suggested to be associated with the time interval from chemoradiotherapy (CRT) completion to surgery. We aimed to evaluate the effect of this time interval for patients with rectal cancer on the pathologic response.

Methods: All patients with rectal cancer undergoing neoadjuvant CRT with evaluable data were selected from among the Health Insurance Review and Assessment Service data. Patients were divided into groups according to the time between CRT and surgery. CRT responses were analyzed.

Results: Two hundred forty-nine patients were included, of whom 86 (34.5%) were in the 5- to 7-week interval, 113 (45.4%) in the 7- to 9-week interval, 38 (15.3%) in the 9- to 11-week interval, and 12 (4.8%) in the >11-week interval. The median time interval between CRT completion and surgery was 7.4 weeks (range: 5?22.7 weeks; interquartile range, 6.7?8.7 weeks). Surgery 9?11 weeks after CRT completion resulted in the highest, but not statistically significant, pathologic complete response (pCR) rate (3 patients, 8.6%; P = 0.886), no pCR was noted in the >11-week interval group. Results
for downstaging in the 9- to 11-week interval group were as follows: T downstaging, 38.2% (P = 0.735); N downstaging, 50.0% (P = 0.439); and TN downstaging, 52.9% (P = 0.087). The 3-year overall survival rates for the 5- to 7-week, 7- to 9-week, 9- to 11-week, and >11-week interval groups were 93.0%, 85.0%, 81.6%, and 91.7%, respectively (P = 0.326).

Conclusion: Delaying surgery by 9 to 11 weeks may increase TN downstaging, but delaying for over 11 weeks may not increase additional tumor downstaging from long-course CRT.

키워드

Neoadjuvant therapy; Rectal neoplasms

원문 및 링크아웃 정보

등재저널 정보

KCI
KoreaMed
KAMS